All hedge funds or institutions that manage over $100M are required by the SEC to file quarterly reports on their holdings.
These reports are called 13F reports. However, the filings are required
the following quarter
from the reporting period,
which means that by the time the filing is made (and we see them), the information could be five months old.
For funds
with long term positions that make few trades, the holdings might closely resemble their current holdings, even after several months. However, for funds that have high turnover,
the holdings data we see might differ significantly from their current holdings. Institutions are required to report CALL and PUT options, and those positions
are identified in the table. However, they are not required to report short positions.
Click the link icon to see the full transaction history.
Upgrade
to unlock premium data and export to Excel 
.
| Security |
Imputed
Share Price |
Prev
Shares |
Current
Shares |
Change
(Percent) |
Prev Value
(USD x1000) |
Current Value
(USD x1000) |
Change
(Percent) |
|---|
| US62857M1053 / MyoKardia, Inc.
|
|
|
|
|
|
|
|
| JNCE / Jounce Therapeutics Inc
|
|
|
|
|
|
|
|
| NEOG / Neogen Corporation
|
|
|
|
|
|
|
|
| CTMX / CytomX Therapeutics, Inc.
|
|
|
|
|
|
|
|
| NTGN / Neon Therapeutics, Inc.
|
|
|
|
|
|
|
|
| IBB / iShares Trust - iShares Biotechnology ETF
|
|
|
|
|
|
|
|
| EVH / Evolent Health, Inc.
|
|
|
|
|
|
|
|
| CLVS / Clovis Oncology Inc
|
|
|
|
|
|
|
|
| OSUR / OraSure Technologies, Inc.
|
|
|
|
|
|
|
|
| CELG / Celgene Corp. Call
|
|
|
|
|
|
|
|
| BOLD / Boundless Bio, Inc.
|
|
|
|
|
|
|
|
| GILD / Gilead Sciences, Inc. Call
|
|
|
|
|
|
|
|
| LOXO / Loxo Oncology, Inc.
|
|
|
|
|
|
|
|
| ONCE / Spark Therapeutics, Inc.
|
|
|
|
|
|
|
|
| NVTA / Invitae Corporation
|
|
|
|
|
|
|
|
| MGTA / Magenta Therapeutics Inc
|
|
|
|
|
|
|
|
| QTNT / Quotient Ltd
|
|
|
|
|
|
|
|
| US3723091043 / GenMark Diagnostics, Inc
|
|
|
|
|
|
|
|
| FIXX / Homology Medicines, Inc.
|
|
|
|
|
|
|
|
| US2103731061 / Constellation Pharmaceuticals Inc
|
|
|
|
|
|
|
|
| GBT / Global Blood Therapeutics Inc.
|
|
|
|
|
|
|
|
| CDNA / CareDx, Inc
|
|
|
|
|
|
|
|
| GRTS / Gritstone bio, Inc.
|
|
|
|
|
|
|
|
| EDIT / Editas Medicine, Inc.
|
|
|
|
|
|
|
|
| BLFS / BioLife Solutions, Inc.
|
|
|
|
|
|
|
|
| ONC / BeOne Medicines AG - Depositary Receipt (Common Stock)
|
|
|
|
|
|
|
|
| VYGR / Voyager Therapeutics, Inc.
|
|
|
|
|
|
|
|
| CRSP / CRISPR Therapeutics AG
|
|
|
|
|
|
|
|
| BPMC / Blueprint Medicines Corporation
|
|
|
|
|
|
|
|
| BLUE / bluebird bio, Inc.
|
|
|
|
|
|
|
|
| SGMO / Sangamo Therapeutics, Inc.
|
|
|
|
|
|
|
|
| FATE / Fate Therapeutics, Inc.
|
|
|
|
|
|
|
|
| SAGE / Sage Therapeutics, Inc.
|
|
|
|
|
|
|
|
| ILMN / Illumina, Inc.
|
|
|
|
|
|
|
|
| ALNY / Alnylam Pharmaceuticals, Inc.
|
|
|
|
|
|
|
|
| SRPT / Sarepta Therapeutics, Inc.
|
|
|
|
|
|
|
|
| CDXS / Codexis, Inc.
|
|
|
|
|
|
|
|
| AGIO / Agios Pharmaceuticals, Inc.
|
|
|
|
|
|
|
|
| DNLI / Denali Therapeutics Inc.
|
|
|
|
|
|
|
|
